1月8日,生成式AI新药研发公司Absci Corporation(NASDAQ: ABSI)宣布与AMD达成战略合作,共同部署AMD Instinct加速器和ROCm软件,以支持关键的人工智能新药研发工作负载,包括Absci从头抗体设计模型。AMD还将以私募股权投资(PIPE)的形式向Absci投资2000万美元。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
No relevant data is available
If the download button clicks without skipping, click on the top right menu and select "Open in Browser."